Innovation in European healthcare – what can Sweden learn? - LIF

The Danish healthcare industry is a significant sector
Specialised in Diabetes care and Biopharmaceuticals.
Measured on market value, Novo Nordisk is by far, the biggest company in DK. It
has a global workforce exceeding 33.900 employees, out of these around 14,600 is
employed in DK. 18% of the total employees work within R & D.
Specialised in dermatological sufferings, and
prevention and treatment of blood clots
LEO Pharma has around 5000 employees world wide, out of these, 1.600 are
placed in DK. 500 of the companies employees work within R & D. Its turnover
and employment rate has been growing steady for many years in a row.
Specialised in disorders such as, psychotic disorders,
epilepsy and Huntington’s, Alzheimer’s and Parkinson’s
diseases
Lundbeck employs 6.000 people worldwide, 2.000 of whom are based in Denmark.
Production is taking place in several different countries. Lundbeck ploughs back
around 20% of its revenue into R&D of new pharmaceuticals and as a result, the
company has research centres on 3 different continents. Lundbeck generated
revenue of approximately 16 billion DKK in 2011.
213
• With a population of 5,58
million, Denmark has a
relatively high employment
within Medtech and
pharmaceutical production.
• In 2010, the export of
pharmaceutical products
reached a record of 52 billion
DKK. Today 90 % of the
Danish pharmaceutical
production is exported.
• Including the areas of nonpharmaceutical
healthcare
products and assistive
technology, the overall
healthcare export amounted to
68 billion DKK in 2010,
corresponding to 12 % of the
overall Danish export.